Evoke Pharma Inc. (EVOK)
4.26
0.03 (0.71%)
At close: Jan 14, 2025, 3:58 PM
4.31
1.17%
After-hours Jan 14, 2025, 03:59 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -0.45 | -1.03 | -1.96 | -4.96 | -5.09 | -5.44 | -2.75 | -1.76 | -1.77 | -2.69 | -6.22 | -7.22 | -174.27 |
| PS Ratio | 0.68 | 3.36 | 10.94 | 2.86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | -1.36 | 2.06 | 4.98 | -20.47 | 8.25 | 10.23 | 15.55 | 4.98 | 6.18 | 3.87 | 0.83 | -0.74 | -23.7 |
| P/FCF Ratio | -0.7 | -1.28 | -1.43 | -9.92 | -6.27 | -5.9 | -3.86 | -2.17 | -2.04 | -3.1 | -5.8 | -8.32 | -144.64 |
| P/OCF Ratio | -0.7 | -1.28 | -1.43 | -9.92 | -6.27 | -5.9 | -3.86 | -2.17 | -2.04 | -3.1 | -5.8 | -8.32 | -144.64 |
| OCF/S Ratio | -0.96 | -2.63 | -7.63 | -288.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | -1.94 | 1.26 | 1.41 | -1.63 | 0.03 | n/a | n/a | n/a | 1.26 | 0.48 | 0.14 | -0.05 | n/a |
| Quick Ratio | 0.66 | 6.91 | 7.38 | 1.20 | 3.10 | 3.46 | 3.82 | 6.58 | 5.19 | 8.15 | 10.69 | 0.20 | 2.71 |
| Current Ratio | 0.71 | 7.08 | 7.51 | 1.23 | 3.10 | 3.46 | 3.82 | 6.58 | 5.19 | 8.15 | 10.69 | 0.20 | 2.71 |
| Asset Turnover | 0.73 | 0.21 | 0.15 | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -14.86 | -15.57 | -16.3 | -115.47 | n/a | -526.83 | -1.72K | -39.34 | n/a | -121.95 | -16.27 | -83.29 | -840.73 |
| Return on Equity (ROE) | 3.02 | -2 | -2.54 | 4.13 | -1.62 | -1.88 | -5.65 | -2.84 | -3.5 | -1.44 | -0.13 | 0.10 | 0.14 |
| Return on Assets (ROA) | -1.1 | -0.69 | -0.85 | -1.41 | -1.11 | -1.34 | -1.54 | -1.16 | -1.27 | -0.87 | -0.11 | -17.39 | -2.65 |
| Return on Capital (ROIC) | 2.88 | -0.76 | -0.89 | -6.87 | -1.63 | -1.99 | -1.91 | -1.34 | -1.54 | -0.98 | -0.11 | 4.41 | -4.23 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 96.10% | 85.24% | 79.72% | -276.68% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -150.41% | -325.36% | -558.03% | -57.61K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -150.41% | -327.83% | -527.66% | -57.14K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -143.44% | -310.37% | -503.79% | -56.68K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -96.22% | -262.93% | -763.43% | -28.80K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -140.76% | -307.9% | -496.76% | -56.65K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |